D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 85 Citations 33,809 363 World Ranking 9441 National Ranking 5004

Overview

What is he best known for?

The fields of study Dan G. Duda is best known for:

  • Cancer
  • Angiogenesis
  • Fibrosis

Cancer research and Breast cancer are two areas of study in which Dan G. Duda engages in interdisciplinary work. Dan G. Duda undertakes interdisciplinary study in the fields of Cancer and Obesity through his works. He regularly links together related areas like Endocrinology in his Obesity studies. In his articles, Dan G. Duda combines various disciplines, including Endocrinology and Oncology. He performs multidisciplinary study in the fields of Oncology and Cancer research via his papers. His Myeloid research extends to the thematically linked field of Internal medicine. As part of his studies on Pancreatic cancer, he often connects relevant areas like Desmoplasia. His research on Desmoplasia often connects related areas such as Pancreatic cancer. His study in Receptor extends to Fibroblast growth factor with its themes.

His most cited work include:

  • None (197 citations)
  • Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice (160 citations)
  • Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2 (130 citations)

What are the main themes of his work throughout his whole career to date

As part of his inquiry into Neovascularization and Angiogenesis inhibitor, Dan G. Duda is doing Angiogenesis research. Dan G. Duda merges Angiogenesis inhibitor with Angiogenesis in his study. Dan G. Duda performs integrative Cancer research and Metastasis research in his work. In his articles, he combines various disciplines, including Genetics and Genetic enhancement. In his works, Dan G. Duda undertakes multidisciplinary study on Cancer and Metastasis. Dan G. Duda conducted interdisciplinary study in his works that combined Internal medicine and Endocrinology. He carries out multidisciplinary research, doing studies in Endocrinology and Internal medicine. He undertakes multidisciplinary investigations into Gene and Genetic enhancement in his work. His Biochemistry study frequently draws connections between adjacent fields such as Mutant.

Dan G. Duda most often published in these fields:

  • Cancer research (57.89%)
  • Genetics (57.89%)
  • Cancer (52.63%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Christopher G Willett;Yves Boucher;Emmanuelle di Tomaso;Dan G Duda.
Nature Medicine (2004)

2415 Citations

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Tracy T. Batchelor;A. Gregory Sorensen;A. Gregory Sorensen;Emmanuelle di Tomaso;Wei Ting Zhang;Wei Ting Zhang.
Cancer Cell (2007)

2002 Citations

NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES

Shom Goel;Dan G. Duda;Lei Xu;Lance L. Munn.
Physiological Reviews (2011)

1466 Citations

Angiogenesis in brain tumours

Rakesh K. Jain;Emmanuelle di Tomaso;Dan G. Duda;Jay S. Loeffler.
Nature Reviews Neuroscience (2007)

1437 Citations

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

Rakesh K Jain;Dan G Duda;Jeffrey W Clark;Jay S Loeffler.
Nature Reviews Clinical Oncology (2006)

1327 Citations

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.

Dai Fukumura;Jonas Kloepper;Zohreh Amoozgar;Dan G. Duda.
Nature Reviews Clinical Oncology (2018)

902 Citations

Engineering vascularized tissue

Rakesh K Jain;Patrick Au;Josh Tam;Dan G Duda.
Nature Biotechnology (2005)

861 Citations

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

Yuhui Huang;Jianping Yuan;Elda Righi;Walid S. Kamoun.
Proceedings of the National Academy of Sciences of the United States of America (2012)

755 Citations

Biomarkers of response and resistance to antiangiogenic therapy.

Rakesh K. Jain;Dan G. Duda;Christopher G. Willett;Dushyant V. Sahani.
Nature Reviews Clinical Oncology (2009)

638 Citations

Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study

Christopher G. Willett;Dan G. Duda;Emmanuelle di Tomaso;Yves Boucher.
Journal of Clinical Oncology (2009)

574 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Dan G. Duda

Rakesh K. Jain

Rakesh K. Jain

Harvard University

Publications: 147

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 112

David A. Reardon

David A. Reardon

Harvard University

Publications: 63

Dai Fukumura

Dai Fukumura

Harvard University

Publications: 61

Peter Carmeliet

Peter Carmeliet

KU Leuven

Publications: 59

Andrew X. Zhu

Andrew X. Zhu

Harvard University

Publications: 59

Josep M. Llovet

Josep M. Llovet

University of Barcelona

Publications: 57

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 53

Tracy T. Batchelor

Tracy T. Batchelor

Brigham and Women's Hospital

Publications: 51

Robert S. Kerbel

Robert S. Kerbel

University of Toronto

Publications: 47

Michael Weller

Michael Weller

University of Zurich

Publications: 45

Gordon C Jayson

Gordon C Jayson

University of Manchester

Publications: 45

Timothy F. Cloughesy

Timothy F. Cloughesy

University of California, Los Angeles

Publications: 43

Ann-Lii Cheng

Ann-Lii Cheng

National Taiwan University

Publications: 38

Napoleone Ferrara

Napoleone Ferrara

University of California, San Diego

Publications: 37

adrian l harris

adrian l harris

University of Oxford

Publications: 37

Trending Scientists

Jagdev Singh

Jagdev Singh

JECRC University

Rajiv Mehrotra

Rajiv Mehrotra

Kodak (France)

Luke J. Mawst

Luke J. Mawst

University of Wisconsin–Madison

Xiong Lu

Xiong Lu

Southwest Jiaotong University

Christine K. Luscombe

Christine K. Luscombe

University of Washington

Hong Qian

Hong Qian

Illinois State Museum

Jeffrey S. Smith

Jeffrey S. Smith

University of Virginia

Nicos A. Nicola

Nicos A. Nicola

Walter and Eliza Hall Institute of Medical Research

Qingyun Duan

Qingyun Duan

Hohai University

A. J. Dolman

A. J. Dolman

Vrije Universiteit Amsterdam

Camillo Marra

Camillo Marra

Agostino Gemelli University Polyclinic

Craig R. Fox

Craig R. Fox

University of California, Los Angeles

Eduardo Bruera

Eduardo Bruera

The University of Texas MD Anderson Cancer Center

Christopher J. Logothetis

Christopher J. Logothetis

The University of Texas MD Anderson Cancer Center

Masafumi Fukagawa

Masafumi Fukagawa

Tokai University

Samuel C. Patterson

Samuel C. Patterson

The Ohio State University

Something went wrong. Please try again later.